Updates are available Correction dated 2018-05-15
Click to view Correction: https://doi.org/10.1038/s41541-018-0055-7
-
Authors
Duthie, Malcolm S.
Pena, Maria T.
Ebenezer, Gigi J.
Gillis, Thomas P.
Sharma, Rahul
Cunningham, Kelly
Polydefkis, Michael
Maeda, Yumi
Makino, Masahiko
Truman, Richard W.
Reed, Steven G.
- License Information
-
More Information
Article History
Received: 18 December 2017
Revised: 15 February 2018
Accepted: 20 February 2018
First Online: 28 March 2018
Change Date: 15 May 2018
Change Type: Correction
Change Details: A source of funding was mistakenly left out of the Acknowledgements. This research was also funded by NIAID/HRSA Interagency Agreement no. AAI15006-004-00000.
Competing interests
: S.G.R. is a founder of, and holds an equity interest in, Immune Design, a licensee of certain rights associated with GLA. S.G.R. and M.S.D. hold a patent on the development of subunit vaccines for leprosy. The other authors declare no competing interests.
